400
Participants
Start Date
September 15, 2023
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
ADSTILADRIN
Non-interventional
RECRUITING
Montefiore Medical Center (Bronx2), The Bronx
RECRUITING
AMP UROLOGY, Syracuse - US Urology Partners, Syracuse
RECRUITING
SUNY Upstate Medical University Syracuse, Syracuse
RECRUITING
Johns Hopkins Hospital, Baltimore
RECRUITING
University of Virginia Health System, Charlottesville
RECRUITING
Urology of Virginia (Virginia Beach), Virginia Beach
RECRUITING
Atlantic Urology Clinics - McLeod Health Blvd, Myrtle Beach
RECRUITING
Emory University, Atlanta
RECRUITING
Georgia Urology, Atlanta
RECRUITING
Mayo Clinic, Jacksonville
RECRUITING
UF Health Surgical Specialists - Gainesville, Gainesville
RECRUITING
Mount Sinai Medical Center, Miami Beach
RECRUITING
Florida Urology Partners, Riverview
RECRUITING
Florida Urology Partners, Tampa
RECRUITING
Florida Urology Partners, Tampa
RECRUITING
Florida Urology Partners, St. Petersburg
RECRUITING
Urology Associates P C (Nashville), Nashville
RECRUITING
Central OH Urology Group - US Urology Partners, Gahanna
RECRUITING
UROLOGY OF INDIANA - GREENWOOD FQ: Urology of Indiana US Uro Partners, Greenwood
RECRUITING
First Urology Research (Jeffersonville), Jeffersonville
RECRUITING
Minnesota Urology, Woodbury
RECRUITING
Mayo Clinic - Rochester Minnesota, Rochester
RECRUITING
Wichita Urology - Wichita Webb, Wichita
RECRUITING
The Urology Center, PC, Omaha
RECRUITING
Arkansas Urology, North Little Rock, Little Rock
RECRUITING
University of Texas Southwestern Medical Center (Dallas), Dallas
RECRUITING
University of Utah (Salt Lake City), Salt Lake City
RECRUITING
Mayo Clinic Arizona, Phoenix
RECRUITING
Banner Health MD Anderson Cancer Center, Gilbert
RECRUITING
USC Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
Urology Associates of Central California, Fresno
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY